Cat allergy in humans is an allergic reaction to one or more allergens produced by cats. The most common of these allergens are the glycoprotein Fel d 1, secreted by the cat's sebaceous glands and Fel d 4, which is expressed in saliva. An allergic reaction is a histamine reaction that is usually characterized by coughing, wheezing, chest tightening, itching, nasal congestion, rash, watering eyes, sneezing, chapped lips, and similar symptoms. In some severe cases, reactions may progress rapidly to cause the victim's airway to become inflamed and close up, requiring emergency medical attention. Those with severe, life-threatening cat allergies face tremendous challenges due to lack of public awareness about anaphylactic cat allergies.
The global market for Cat Allergy in Humans was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 638%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cat Allergy in Humans, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cat Allergy in Humans by region & country, by Type, and by Application.
The Cat Allergy in Humans market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cat Allergy in Humans.
麻豆原创 Segmentation
By Company
SANOFI
Bayer
Glaxo SmithKline
Johnson & Johnson Consumer Inc
Pfizer
Alen
Rabbit Air
Blueair Classic
WINIX
Honeywell
Nature's Miracle
Pledge
Ecology Works
MESSY PET CAT
Stallergenes Greer
HAL
HollisterStier Allergy
Allergy Therapeutics
Segment by Type:
Symptom Relief Drug
Air Purifier
Allergen Blocker
Allergy Immunotherapy
Other
Segment by Application
Allergy Treatment
Allergy Prevention
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cat Allergy in Humans manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cat Allergy in Humans in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cat Allergy in Humans in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Cat Allergy in Humans Product Introduction
1.2 Global Cat Allergy in Humans 麻豆原创 Size Forecast
1.3 Cat Allergy in Humans 麻豆原创 Trends & Drivers
1.3.1 Cat Allergy in Humans Industry Trends
1.3.2 Cat Allergy in Humans 麻豆原创 Drivers & Opportunity
1.3.3 Cat Allergy in Humans 麻豆原创 Challenges
1.3.4 Cat Allergy in Humans 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cat Allergy in Humans Players Revenue Ranking (2023)
2.2 Global Cat Allergy in Humans Revenue by Company (2019-2024)
2.3 Key Companies Cat Allergy in Humans Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cat Allergy in Humans Product Offered
2.5 Key Companies Time to Begin Mass Production of Cat Allergy in Humans
2.6 Cat Allergy in Humans 麻豆原创 Competitive Analysis
2.6.1 Cat Allergy in Humans 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cat Allergy in Humans Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cat Allergy in Humans as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Symptom Relief Drug
3.1.2 Air Purifier
3.1.3 Allergen Blocker
3.1.4 Allergy Immunotherapy
3.1.5 Other
3.2 Global Cat Allergy in Humans Sales Value by Type
3.2.1 Global Cat Allergy in Humans Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cat Allergy in Humans Sales Value, by Type (2019-2030)
3.2.3 Global Cat Allergy in Humans Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Allergy Treatment
4.1.2 Allergy Prevention
4.2 Global Cat Allergy in Humans Sales Value by Application
4.2.1 Global Cat Allergy in Humans Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cat Allergy in Humans Sales Value, by Application (2019-2030)
4.2.3 Global Cat Allergy in Humans Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cat Allergy in Humans Sales Value by Region
5.1.1 Global Cat Allergy in Humans Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cat Allergy in Humans Sales Value by Region (2019-2024)
5.1.3 Global Cat Allergy in Humans Sales Value by Region (2025-2030)
5.1.4 Global Cat Allergy in Humans Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cat Allergy in Humans Sales Value, 2019-2030
5.2.2 North America Cat Allergy in Humans Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cat Allergy in Humans Sales Value, 2019-2030
5.3.2 Europe Cat Allergy in Humans Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cat Allergy in Humans Sales Value, 2019-2030
5.4.2 Asia Pacific Cat Allergy in Humans Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cat Allergy in Humans Sales Value, 2019-2030
5.5.2 South America Cat Allergy in Humans Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cat Allergy in Humans Sales Value, 2019-2030
5.6.2 Middle East & Africa Cat Allergy in Humans Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cat Allergy in Humans Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cat Allergy in Humans Sales Value
6.3 United States
6.3.1 United States Cat Allergy in Humans Sales Value, 2019-2030
6.3.2 United States Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cat Allergy in Humans Sales Value, 2019-2030
6.4.2 Europe Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cat Allergy in Humans Sales Value, 2019-2030
6.5.2 China Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cat Allergy in Humans Sales Value, 2019-2030
6.6.2 Japan Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cat Allergy in Humans Sales Value, 2019-2030
6.7.2 South Korea Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cat Allergy in Humans Sales Value, 2019-2030
6.8.2 Southeast Asia Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cat Allergy in Humans Sales Value, 2019-2030
6.9.2 India Cat Allergy in Humans Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cat Allergy in Humans Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 SANOFI
7.1.1 SANOFI Profile
7.1.2 SANOFI Main Business
7.1.3 SANOFI Cat Allergy in Humans Products, Services and Solutions
7.1.4 SANOFI Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.1.5 SANOFI Recent Developments
7.2 Bayer
7.2.1 Bayer Profile
7.2.2 Bayer Main Business
7.2.3 Bayer Cat Allergy in Humans Products, Services and Solutions
7.2.4 Bayer Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.2.5 Bayer Recent Developments
7.3 Glaxo SmithKline
7.3.1 Glaxo SmithKline Profile
7.3.2 Glaxo SmithKline Main Business
7.3.3 Glaxo SmithKline Cat Allergy in Humans Products, Services and Solutions
7.3.4 Glaxo SmithKline Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Consumer Inc Recent Developments
7.4 Johnson & Johnson Consumer Inc
7.4.1 Johnson & Johnson Consumer Inc Profile
7.4.2 Johnson & Johnson Consumer Inc Main Business
7.4.3 Johnson & Johnson Consumer Inc Cat Allergy in Humans Products, Services and Solutions
7.4.4 Johnson & Johnson Consumer Inc Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Consumer Inc Recent Developments
7.5 Pfizer
7.5.1 Pfizer Profile
7.5.2 Pfizer Main Business
7.5.3 Pfizer Cat Allergy in Humans Products, Services and Solutions
7.5.4 Pfizer Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer Recent Developments
7.6 Alen
7.6.1 Alen Profile
7.6.2 Alen Main Business
7.6.3 Alen Cat Allergy in Humans Products, Services and Solutions
7.6.4 Alen Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.6.5 Alen Recent Developments
7.7 Rabbit Air
7.7.1 Rabbit Air Profile
7.7.2 Rabbit Air Main Business
7.7.3 Rabbit Air Cat Allergy in Humans Products, Services and Solutions
7.7.4 Rabbit Air Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.7.5 Rabbit Air Recent Developments
7.8 Blueair Classic
7.8.1 Blueair Classic Profile
7.8.2 Blueair Classic Main Business
7.8.3 Blueair Classic Cat Allergy in Humans Products, Services and Solutions
7.8.4 Blueair Classic Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.8.5 Blueair Classic Recent Developments
7.9 WINIX
7.9.1 WINIX Profile
7.9.2 WINIX Main Business
7.9.3 WINIX Cat Allergy in Humans Products, Services and Solutions
7.9.4 WINIX Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.9.5 WINIX Recent Developments
7.10 Honeywell
7.10.1 Honeywell Profile
7.10.2 Honeywell Main Business
7.10.3 Honeywell Cat Allergy in Humans Products, Services and Solutions
7.10.4 Honeywell Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.10.5 Honeywell Recent Developments
7.11 Nature's Miracle
7.11.1 Nature's Miracle Profile
7.11.2 Nature's Miracle Main Business
7.11.3 Nature's Miracle Cat Allergy in Humans Products, Services and Solutions
7.11.4 Nature's Miracle Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.11.5 Nature's Miracle Recent Developments
7.12 Pledge
7.12.1 Pledge Profile
7.12.2 Pledge Main Business
7.12.3 Pledge Cat Allergy in Humans Products, Services and Solutions
7.12.4 Pledge Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.12.5 Pledge Recent Developments
7.13 Ecology Works
7.13.1 Ecology Works Profile
7.13.2 Ecology Works Main Business
7.13.3 Ecology Works Cat Allergy in Humans Products, Services and Solutions
7.13.4 Ecology Works Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.13.5 Ecology Works Recent Developments
7.14 MESSY PET CAT
7.14.1 MESSY PET CAT Profile
7.14.2 MESSY PET CAT Main Business
7.14.3 MESSY PET CAT Cat Allergy in Humans Products, Services and Solutions
7.14.4 MESSY PET CAT Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.14.5 MESSY PET CAT Recent Developments
7.15 Stallergenes Greer
7.15.1 Stallergenes Greer Profile
7.15.2 Stallergenes Greer Main Business
7.15.3 Stallergenes Greer Cat Allergy in Humans Products, Services and Solutions
7.15.4 Stallergenes Greer Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.15.5 Stallergenes Greer Recent Developments
7.16 HAL
7.16.1 HAL Profile
7.16.2 HAL Main Business
7.16.3 HAL Cat Allergy in Humans Products, Services and Solutions
7.16.4 HAL Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.16.5 HAL Recent Developments
7.17 HollisterStier Allergy
7.17.1 HollisterStier Allergy Profile
7.17.2 HollisterStier Allergy Main Business
7.17.3 HollisterStier Allergy Cat Allergy in Humans Products, Services and Solutions
7.17.4 HollisterStier Allergy Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.17.5 HollisterStier Allergy Recent Developments
7.18 Allergy Therapeutics
7.18.1 Allergy Therapeutics Profile
7.18.2 Allergy Therapeutics Main Business
7.18.3 Allergy Therapeutics Cat Allergy in Humans Products, Services and Solutions
7.18.4 Allergy Therapeutics Cat Allergy in Humans Revenue (US$ Million) & (2019-2024)
7.18.5 Allergy Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Cat Allergy in Humans Industrial Chain
8.2 Cat Allergy in Humans Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cat Allergy in Humans Sales Model
8.5.2 Sales Channel
8.5.3 Cat Allergy in Humans Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
SANOFI
Bayer
Glaxo SmithKline
Johnson & Johnson Consumer Inc
Pfizer
Alen
Rabbit Air
Blueair Classic
WINIX
Honeywell
Nature's Miracle
Pledge
Ecology Works
MESSY PET CAT
Stallergenes Greer
HAL
HollisterStier Allergy
Allergy Therapeutics
听
听
*If Applicable.
